Drugplain

Zilretta

triamcinolone acetonide extended-release injectable suspension · KIT · Pacira Pharmaceuticals, Inc.

No Recall HistoryCurrently in Shortage
Plain English

Zilretta is a kit containing triamcinolone acetonide extended-release injectable suspension, taken intra-articular. Manufactured by Pacira Pharmaceuticals, Inc..

Key Facts

Brand Name
Zilretta
Generic Name
triamcinolone acetonide extended-release injectable suspension
NDC Code (Product)
65250-003
Manufacturer
Pacira Pharmaceuticals, Inc.
Dosage Form
KIT
Route
INTRA-ARTICULAR
Marketing Status
Application #
NDA208845
Marketing Start
10/06/2017

Recall History

No Recall History

Frequently Asked Questions

What is Zilretta used for?

Zilretta contains triamcinolone acetonide extended-release injectable suspension. It is a kit taken intra-articular. Consult your doctor for specific uses.

Is Zilretta a controlled substance?

Zilretta is not classified as a controlled substance by the DEA.

What is the generic name for Zilretta?

The generic name for Zilretta is triamcinolone acetonide extended-release injectable suspension. There are no other listed brand versions of triamcinolone acetonide extended-release injectable suspension.

What is the NDC code for Zilretta ?

The NDC (National Drug Code) for Zilretta is 65250-003, listed by Pacira Pharmaceuticals, Inc..

Product NDC

65250-003

Package NDC

65250-003-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)